14 completed, 3 unknown, 2 terminated. 19 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 19 | Completed 14, Unknown 3, Terminated 2 |
Follow Amisulpride: new trials by email Literature Review of Amisulpride trials Research Report on Amisulpride
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Atypical Antipsychotics Influence on the Safety of the Heart and Monitoring Indicators Model Building Risperidone, Aripiprazole, Ziprasidone - Schizophrenia | Phase 4 | Unknown | Shanghai Mental Health Center | 350 | 2021-05-01 | 2020-08-26 |
| Low Dose Amisulpride Vs Olanzapine-Fluoxetine Combination in Post-Schizophrenic Depression Amisulpride, Olanzapine-Fluoxetine Combination - Post-Schizophrenic Depression | Phase 4 | Completed | All India Institute of Medical Sciences, Bhubaneswar | 60 | 2019-10-14 | 2024-09-19 |
| Disturbance of Plasma Cytokine Parameters in Clozapine-Resistant Treatment-Refractory Schizophrenia (CTRS) and Their Association With Combination Therapy sodium valproate with Clozapine, modified electroconvulsive therapy(MECT) with Clozapine, amisulpride with Clozapine - Schizophrenia | Phase 4 | Completed | Shanghai Mental Health Center | 145 | 2018-09-06 | 2022-09-06 |
| Clinical Evaluation of Acupuncture Treatment for Negative Symptoms of Schizophrenia acupuncture, Amisulpride - Schizophrenia | Phase 4 | Unknown | Shanghai Mental Health Center | 50 | 2017-10-01 | 2019-01-14 |
| Evaluation of the Necessity of Long-term Pharmacological Treatment With Antipsychotics in Schizophrenic Patients Olanzapine, Amisulpride, Risperidone - Schizophrenia, Schizophrenia and Disorders With Psychotic Features | Phase 4 | Completed | Technical University of Munich | 21 | 2015-02-01 | 2018-10-11 |
| Association of Amisulpride Response in Schizophrenia With Brain Image amisulpride - Schizophrenia, Schizophreniform Disorder | Phase 4 | Unknown | CHA University | 20 | 2014-01-01 | 2014-03-26 |
| Effectiveness and Safety of Amisulpride in Chinese Patients With Schizophrenia AMISULPRIDE - Schizophrenia | Phase 4 | Completed | Sanofi | 316 | 2012-11-01 | 2015-01-22 |
| Comparison of Antipsychotic Combination Treatment of Olanzapine and Amisulpride to Monotherapy Olanzapine, Amisulpride, Olanzapine and Amisulpride - Schizophrenia, Schizoaffective Disorder | Phase 4 | Completed | Heinrich-Heine University, Duesseldorf | 328 | 2012-06-01 | 2019-04-16 |
| Bergen Psychosis Project 2 - The Best Intro Study Amisulpride, Aripiprazole, Olanzapine - Schizophrenia, Psychotic Disorders | Phase 4 | Completed | Haukeland University Hospital | 151 | 2011-10-01 | 2020-06-19 |
| Amisulpride Augmentation in Clozapine-unresponsive Schizophrenia Amisulpride, placebo - Schizophrenia | Phase 4 | Completed | Imperial College London | 69 | 2011-09-01 | 2015-04-01 |
| Efficacy Study on Cognitive Functions in Schizophrenic Patients amisulpride and risperidone - Schizophrenia | Phase 4 | Completed | Sanofi | 37 | 2008-09-01 | 2010-12-09 |
| A Randomized, Double-blind, Comparison of the Efficacy and Safety of Amisulpride Versus Low-dose Amisulpride Plus Low-dose Sulpiride in the Treatment of Schizophrenia full-dose amisulpride - Schizophrenia | Phase 4 | Terminated | Kaohsiung Kai-Suan Psychiatric Hospital | 96 | 2008-01-01 | 2016-03-01 |
| SOLIACS: Solian Solution in the Acute Setting amisulpride - Schizophrenia | Phase 4 | Completed | Sanofi | 300 | 2005-06-01 | 2008-04-10 |
| Amisulpride in Schizophrenic Acute Phase Patients Amisulpride - Schizophrenia | Phase 4 | Completed | Sanofi | 50 | 2005-05-01 | 2008-09-05 |
| SWitching to Abilify Trial (SWAT) Aripiprazole, Solian, Olanzapine, Seroquel, Risperidone - Schizophrenia | Phase 4 | Completed | Korea Otsuka Pharmaceutical Co., Ltd. | 500 | 2004-10-01 | 2009-12-17 |
| Amisulpride in Schizophrenic Patients Amisulpride - Schizophrenia | Phase 4 | Completed | Sanofi | 138 | 2004-02-01 | 2008-04-10 |
| Tardive Dyskinesia and Cognitive Function amisulpride, Olanzapine, Conventional antipsychotics - Tardive Dyskinesia, Neurocognitive Function | Phase 4 | Completed | Taipei Veterans General Hospital, Taiwan | 80 | 2003-01-01 | 2009-06-24 |
| Modulation of Regional Brain Activation in Schizophrenic Patients by Pharmacological Therapy Amisulpride, Olanzapine, Haloperidol - Schizophrenia | Phase 4 | Terminated | University of Jena | 19 | 2003-01-01 | 2008-09-16 |
| Early Pharmacological and Psychological Intervention for Late Prodromal States of Psychosis Supportive management, Amisulpride - Schizophrenia, Psychoses | Phase 4 | Completed | University of Cologne | 124 | 2001-01-01 | 2014-12-24 |
Schizophrenia (17) · Psychotic Disorders (5) · Prodromal Symptoms (1) · Schizophrenia Spectrum and Other Psychotic Disorders (1) · Tardive Dyskinesia (1)
Sanofi (5) · Shanghai Mental Health Center (3) · All India Institute of Medical Sciences, Bhubaneswar (1) · CHA University (1) · Haukeland University Hospital (1) · Heinrich-Heine University, Duesseldorf (1) · Imperial College London (1) · Kaohsiung Kai-Suan Psychiatric Hospital (1) · Korea Otsuka Pharmaceutical Co., Ltd. (1) · Taipei Veterans General Hospital, Taiwan (1) · Technical University of Munich (1) · University of Cologne (1) · University of Jena (1)
China (4) · Germany (3) · South Korea (2) · Taiwan (2) · Austria (1) · Belgium (1) · Hong Kong (1) · Hungary (1) · India (1) · Norway (1) · United Kingdom (1)
Biswa R Mishra, MD (1) · Chang-Yoon Kim, Prof. (1) · Ching-Hua Lin, MD, PhD (1) · Christian Schmidt-Kraepelin, Dr. (1) · Dr. Christian Fassotte, M.D. (1) · Elaine Tang (1) · Erik Johnsen, M.D., Ph.D. (1) · Markus Dold, MD (1) · Sang-Hyuk Lee, MD., PhD. (1) · Stefan Leucht, Professor (1)
PMID 11229973, PMID 12747876, PMID 15521794, PMID 16870959, PMID 23778382, PMID 28461752, PMID 28721051, PMID 33069317, PMID 34408155, PMID 35131596, PMID 35276079, PMID 36253804, PMID 37386462, PMID 38560960, PMID 38958149, PMID 40770798, PMID 42033308